lol
Hemispherx Biopharma, Inc. Announces $5 Million Registered Direct Offering
In connection with the offering, the Company will issue registered shares of common stock at a purchase price of $1.50 per share. Concurrently in a private placement, for each share of common stock purchased by an investor, such investor will receive from the Company an unregistered warrant to purchase 0.75 shares of common stock. The warrants have an exercise price of $2.00 per share, will be exercisable six months after issuance and will expire five years from the initial exercise date.
ir.hemispherx.net/profiles/investor/...=0&LangID=1&s=0